Clinical trial
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational…
NCT00398645 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00398645 |
|---|---|
| Title | A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200 mcg Twice Daily, GW685698X 200 mcg and 400 mcg Once Daily in the Morning, and GW685698X 200 mcg and 400 mcg Once Daily in the Evening Compared With Placebo for 8… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW685698X 200mcg, GW685698X 200mcg and 400mcg |
| Enrollment | 648 |
| Start date | Nov 15, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 30, 2007 |
| First posted | Nov 14, 2006 |
| Last update posted | Jan 23, 2018 |
| Countries | Australia, Bulgaria, Canada, Chile, Croatia, Germany, Israel, Mexico, New Zealand, Peru, Philippines, Russia and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: